BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24028612)

  • 1. Improved percutaneous delivery of ketoprofen using combined application of nanocarriers and silicon microneedles.
    Vučen SR; Vuleta G; Crean AM; Moore AC; Ignjatović N; Uskoković D
    J Pharm Pharmacol; 2013 Oct; 65(10):1451-62. PubMed ID: 24028612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration and distribution of PLGA nanoparticles in the human skin treated with microneedles.
    Zhang W; Gao J; Zhu Q; Zhang M; Ding X; Wang X; Hou X; Fan W; Ding B; Wu X; Wang X; Gao S
    Int J Pharm; 2010 Dec; 402(1-2):205-12. PubMed ID: 20932886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical ketoprofen nanogel: artificial neural network optimization, clustered bootstrap validation, and in vivo activity evaluation based on longitudinal dose response modeling.
    Elkomy MH; Elmenshawe SF; Eid HM; Ali AM
    Drug Deliv; 2016 Nov; 23(9):3294-3306. PubMed ID: 27066917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable Ingredient-Based Emulgel Loaded with Ketoprofen Nanoparticles.
    Gul R; Ahmed N; Ullah N; Khan MI; Elaissari A; Rehman AU
    AAPS PharmSciTech; 2018 May; 19(4):1869-1881. PubMed ID: 29651679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of poly(glycerol adipate) nanoparticles loaded with non-steroidal anti-inflammatory drugs.
    Wahab A; Favretto ME; Onyeagor ND; Khan GM; Douroumis D; Casely-Hayford MA; Kallinteri P
    J Microencapsul; 2012; 29(5):497-504. PubMed ID: 22769722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel bilayer dissolving microneedle arrays with concentrated PLGA nano-microparticles for targeted intradermal delivery: Proof of concept.
    Vora LK; Donnelly RF; Larrañeta E; González-Vázquez P; Thakur RRS; Vavia PR
    J Control Release; 2017 Nov; 265():93-101. PubMed ID: 29037785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and Antiinflammatory Effect of a Novel Gel System Containing Ketoprofen Solid Nanoparticles.
    Nagai N; Iwamae A; Tanimoto S; Yoshioka C; Ito Y
    Biol Pharm Bull; 2015; 38(12):1918-24. PubMed ID: 26632183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery.
    Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
    Int J Pharm; 2005 Jul; 298(1):55-67. PubMed ID: 15941634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.
    Sanna V; Gavini E; Cossu M; Rassu G; Giunchedi P
    J Pharm Pharmacol; 2007 Aug; 59(8):1057-64. PubMed ID: 17725847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced transdermal delivery of ketoprofen from bioadhesive gels.
    Singh S; Gajra B; Rawat M; Muthu MS
    Pak J Pharm Sci; 2009 Apr; 22(2):193-8. PubMed ID: 19339232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro permeation studies of nanoemulsions containing ketoprofen as a model drug.
    Kim BS; Won M; Lee KM; Kim CS
    Drug Deliv; 2008 Sep; 15(7):465-9. PubMed ID: 18712624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of microneedle on the pharmacokinetics of ketoprofen from its transdermal formulations.
    So JW; Park HH; Lee SS; Kim DC; Shin SC; Cho CW
    Drug Deliv; 2009 Jan; 16(1):52-6. PubMed ID: 19555309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterisation of novel analgesic product based on self-regulating drug carriers.
    Cevc G; Vierl U; Mazgareanu S
    Int J Pharm; 2008 Aug; 360(1-2):18-28. PubMed ID: 18524509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occlusion effect on transcutaneous NSAID delivery from conventional and carrier-based formulations.
    Cevc G; Mazgareanu S; Rother M; Vierl U
    Int J Pharm; 2008 Jul; 359(1-2):190-7. PubMed ID: 18499370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of permeation enhancers on the release of ketoprofen through transdermal drug delivery systems.
    Singh SK; Durrani MJ; Reddy IK; Khan MA
    Pharmazie; 1996 Oct; 51(10):741-4. PubMed ID: 8941942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid nanoparticles for prolonged topical delivery: an in vitro and in vivo investigation.
    Puglia C; Blasi P; Rizza L; Schoubben A; Bonina F; Rossi C; Ricci M
    Int J Pharm; 2008 Jun; 357(1-2):295-304. PubMed ID: 18343059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ketoprofen Microemulsion for Improved Skin Delivery and In Vivo Anti-inflammatory Effect.
    Aliberti ALM; de Queiroz AC; Praça FSG; Eloy JO; Bentley MVLB; Medina WSG
    AAPS PharmSciTech; 2017 Oct; 18(7):2783-2791. PubMed ID: 28374340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cremophor RH40-PEG 400 microemulsions as transdermal drug delivery carrier for ketoprofen.
    Ngawhirunpat T; Worachun N; Opanasopit P; Rojanarata T; Panomsuk S
    Pharm Dev Technol; 2013; 18(4):798-803. PubMed ID: 22023398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microneedle-assisted delivery of verapamil hydrochloride and amlodipine besylate.
    Kaur M; Ita KB; Popova IE; Parikh SJ; Bair DA
    Eur J Pharm Biopharm; 2014 Feb; 86(2):284-91. PubMed ID: 24176676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of colloidal modified nanolipid carrier: application to topical delivery of tacrolimus.
    Pople PV; Singh KK
    Eur J Pharm Biopharm; 2011 Sep; 79(1):82-94. PubMed ID: 21447390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.